How many stocks are there of Athenex?
The current number of stocks of Athenex is 6.54 M undefined.
Athenex Stocks 2024
Athenex Stocks
6.54 M
Ticker
ATNX
ISIN
US04685N1037
WKN
A2DTE9
In 2024, Athenex had 6.54 M outstanding stocks, a 0% change from the 6.54 M stocks in the previous year.
The Athenex Stocks history
| YEAR | NUMBER OF STOCKS (undefined USD) |
|---|---|
| 2026e | 6.54 |
| 2025e | 6.54 |
| 2024e | 6.54 |
| 2023e | 6.54 |
| 2022 | 6.54 |
| 2021 | 5.2 |
| 2020 | 4.25 |
| 2019 | 74.1 |
| 2018 | 64.6 |
| 2017 | 50 |
| 2016 | 55.2 |
| 2015 | 55.2 |
| 2014 | 55.2 |
Athenex shares outstanding US04685N1037 · A2DTE9
The number of shares was Athenex in 2023 — This indicates how many shares 6.541 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.
3 years
5 years
10 years
25 Years
Max
Number of stocks
Details
Revenue, EBIT and Earnings per share
ⓘRevenue Per Share
Revenue per share represents the total revenue Athenex earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.
EBIT Per Share
EBIT per share indicates Athenex's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.
Income Per Share
Income per share, or earnings per share (EPS), reveals the portion of Athenex’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.
Expected Values
Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Athenex's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.
| Number of stocks | |
|---|---|
| 2014 | 55.2 M Aktien |
| 2015 | 55.2 M Aktien |
| 2016 | 55.2 M Aktien |
| 2017 | 50 M Aktien |
| 2018 | 64.6 M Aktien |
| 2019 | 74.1 M Aktien |
| 2020 | 4.25 M Aktien |
| 2021 | 5.2 M Aktien |
| 2022 | 6.54 M Aktien |
| 2023e | 6.54 M Aktien |
| 2024e | 6.54 M Aktien |
| 2025e | 6.54 M Aktien |
| 2026e | 6.54 M Aktien |
Athenex Aktienanalyse
What does Athenex do?
Athenex Inc was founded in 2003 and is headquartered in Buffalo, New York. The company specializes in the development and marketing of innovative drugs and therapies for the treatment of cancer and other serious diseases. Athenex's business model is based on collaboration with other companies and research institutions. The company works closely with academic partners to identify and develop new technologies and active ingredients. Athenex has also entered into several collaboration agreements with major pharmaceutical companies to facilitate the marketing of its products. The company has multiple divisions: Athenex Pharmaceutical Division, Athenex Oncology Division, and Athenex Pharmaceutical Technology Division. The Athenex Pharmaceutical Division focuses on the development and marketing of drugs for the treatment of cancer and other serious illnesses. The company has several promising drug candidates in its pipeline, including Oratopo, a drug for the treatment of breast cancer, and KX-2-391, a drug for the treatment of prostate cancer. The Athenex Oncology Division focuses on the development and marketing of innovative cancer treatment methods. The company has several promising therapy approaches in its pipeline, including an immunological cancer treatment based on activating the immune system to fight cancer cells. The Athenex Pharmaceutical Technology Division utilizes advanced technologies to improve the effectiveness and tolerability of drugs, including novel drug delivery systems and innovative packaging forms. Athenex also offers a wide range of products and services for the pharmaceutical industry, including drug development and manufacturing, as well as the supply of active ingredients and excipients. Overall, Athenex has a broad and interesting business model and a promising portfolio of drug candidates and therapy approaches in its pipeline. The company has also established strong partnerships with other companies and research institutions to advance its development and marketing of drugs and therapies. Athenex ist eines der beliebtesten Unternehmen auf Eulerpool.com.Stocks Details
Evaluating Athenex's Shares Outstanding
Athenex's shares outstanding refer to the total number of shares that are currently held by all its shareholders, including institutional investors and restricted shares held by the company’s officers and insiders. The number of shares outstanding is crucial in determining the company's market capitalization and is used by investors to assess the company’s size, financial health, and investment potential.
Year-to-Year Comparison
Tracking the changes in Athenex’s shares outstanding over the years can provide investors with insights into the company's financial strategies and market valuation. An increase in shares outstanding can result from actions like issuing new shares, while a decrease can result from buybacks.
Impact on Investments
For investors, understanding Athenex’s shares outstanding is essential for evaluating its earnings per share (EPS) and market valuation. A change in the number of shares outstanding can impact the EPS, which is a significant driver of stock prices and investor decisions.
Interpreting Changes in Shares Outstanding
Variances in Athenex’s shares outstanding can signal shifts in the company’s financial strategy. An increase may dilute the EPS and share value, indicating potential fundraising or acquisitions. Conversely, a decrease, often due to share buybacks, can enhance share value and indicate the company’s confidence in its financial performance.
Frequently Asked Questions about Athenex stock
What does Number of Shares / OutstandingShares mean?
The outstanding shares (or issued shares) of Athenex are the total number of shares issued and actively held by shareholders - both external investors and company insiders. However, these must be actual shares. may grant stock options to executives that can be converted into shares.
How has the number of shares of Athenex evolved in recent years?
The number of shares of Athenex has increased by 0% gestiegen compared to last year.
What does the number of shares mean for investors?
The number of shares outstanding is used to calculate key metrics such as a company's market capitalization, earnings per share (EPS), and cash flow per share (CFPS). The number of outstanding shares of a company is not static and can fluctuate greatly over time.
Why does the number of stocks fluctuate?
There are various factors that can lead to a change. Athenex as a company can issue new shares, carry out stock splits or reverse splits.
Does the number of shares have an impact on the performance of Athenex?
There is no tangible long-term evidence or study that stocks with a certain number of shares (regardless of Mega/Large/Mid/Small Cap) would yield significantly higher returns than others. There are occasional small studies (limited number of stocks, short investment period) that certain classes outperform or have higher risk, but none of them are 1. conclusive (cause-effect is unclear, experiment is not repeatable) or 2. generalizable (generalization is not possible due to small sample size and time period).
How much dividend does Athenex pay?
Over the past 12 months, Athenex paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Athenex is expected to pay a dividend of 0 USD.
What is the dividend yield of Athenex?
The current dividend yield of Athenex is .
When does Athenex pay dividends?
Athenex pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Athenex?
Athenex paid dividends every year for the past 0 years.
What is the dividend of Athenex?
For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.
In which sector is Athenex located?
Athenex is assigned to the 'Health' sector.
Wann musste ich die Aktien von Athenex kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Athenex from 12/2/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 12/2/2024.
When did Athenex pay the last dividend?
The last dividend was paid out on 12/2/2024.
What was the dividend of Athenex in the year 2023?
In the year 2023, Athenex distributed 0 USD as dividends.
In which currency does Athenex pay out the dividend?
The dividends of Athenex are distributed in USD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Athenex
Our stock analysis for Athenex Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Athenex Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
